IDEAYA Biosciences (IDYA) Misses Q2 EPS by 9c

IDEAYA Biosciences (NASDAQ: IDYA) reported Q2 EPS of ($0.88), $0.09 worse than the analyst estimate of ($0.79).

For earnings history and earnings-related data on IDEAYA Biosciences (IDYA) click here.

You May Also Be Interested In

• BofA says convenience store sales trail broader retail channels
• Citi Upgrades Cochlear Ltd. (COH:AU) to Neutral
• Meta Platforms (META) call put ratio 1 call to 1.1 puts with a focus on August 19 weekly 682.50 calls